193 related articles for article (PubMed ID: 36477079)
1. Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway.
Belmonte-Fernández A; Herrero-Ruíz J; Galindo-Moreno M; Limón-Mortés MC; Mora-Santos M; Sáez C; Japón MÁ; Tortolero M; Romero F
Cell Death Differ; 2023 Feb; 30(2):488-499. PubMed ID: 36477079
[TBL] [Abstract][Full Text] [Related]
2. Deletion of NAD(P)H:quinone oxidoreductase 1 represses Mre11-Rad50-Nbs1 complex protein expression in cisplatin-induced nephrotoxicity.
Kim YJ; Kim TW; Park SR; Kim HT; Jung DY; Ryu SY; Jung JY
Toxicol Lett; 2016 Jan; 243():22-30. PubMed ID: 26723870
[TBL] [Abstract][Full Text] [Related]
3. Variations in Mre11/Rad50/Nbs1 status and DNA damage-induced S-phase arrest in the cell lines of the NCI60 panel.
Garner KM; Eastman A
BMC Cancer; 2011 May; 11():206:1-13. PubMed ID: 21619594
[TBL] [Abstract][Full Text] [Related]
4. Ataxia telangiectasia-mutated (ATM) kinase activity is regulated by ATP-driven conformational changes in the Mre11/Rad50/Nbs1 (MRN) complex.
Lee JH; Mand MR; Deshpande RA; Kinoshita E; Yang SH; Wyman C; Paull TT
J Biol Chem; 2013 May; 288(18):12840-51. PubMed ID: 23525106
[TBL] [Abstract][Full Text] [Related]
5. Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy.
Abuzeid WM; Jiang X; Shi G; Wang H; Paulson D; Araki K; Jungreis D; Carney J; O'Malley BW; Li D
J Clin Invest; 2009 Jul; 119(7):1974-85. PubMed ID: 19487811
[TBL] [Abstract][Full Text] [Related]
6. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
Bartkova J; Tommiska J; Oplustilova L; Aaltonen K; Tamminen A; Heikkinen T; Mistrik M; Aittomäki K; Blomqvist C; Heikkilä P; Lukas J; Nevanlinna H; Bartek J
Mol Oncol; 2008 Dec; 2(4):296-316. PubMed ID: 19383352
[TBL] [Abstract][Full Text] [Related]
7. Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex.
Lentz TB; Samulski RJ
J Virol; 2015 Jan; 89(1):181-94. PubMed ID: 25320294
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma.
Shen B; Huang D; Ramsey AJ; Ig-Izevbekhai K; Zhang K; Lajud SA; O'Malley BW; Li D
Br J Cancer; 2020 Mar; 122(5):640-647. PubMed ID: 31853007
[TBL] [Abstract][Full Text] [Related]
9. β-Lapachone enhances Mre11-Rad50-Nbs1 complex expression in cisplatin-induced nephrotoxicity.
Kim TW; Kim YJ; Kim HT; Park SR; Jung JY
Pharmacol Rep; 2016 Feb; 68(1):27-31. PubMed ID: 26721347
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism.
Sohn SY; Hearing P
J Virol; 2012 Sep; 86(18):9656-65. PubMed ID: 22740413
[TBL] [Abstract][Full Text] [Related]
11. MRE11-RAD50-NBS1 Complex Is Sufficient to Promote Transcription by RNA Polymerase II at Double-Strand Breaks by Melting DNA Ends.
Sharma S; Anand R; Zhang X; Francia S; Michelini F; Galbiati A; Williams H; Ronato DA; Masson JY; Rothenberg E; Cejka P; d'Adda di Fagagna F
Cell Rep; 2021 Jan; 34(1):108565. PubMed ID: 33406426
[TBL] [Abstract][Full Text] [Related]
12. Replication protein A and the Mre11.Rad50.Nbs1 complex co-localize and interact at sites of stalled replication forks.
Robison JG; Elliott J; Dixon K; Oakley GG
J Biol Chem; 2004 Aug; 279(33):34802-10. PubMed ID: 15180989
[TBL] [Abstract][Full Text] [Related]
13. NBS1 is regulated by two kind of mechanisms: ATM-dependent complex formation with MRE11 and RAD50, and cell cycle-dependent degradation of protein.
Zhou H; Kawamura K; Yanagihara H; Kobayashi J; Zhang-Akiyama QM
J Radiat Res; 2017 Jul; 58(4):487-494. PubMed ID: 28369484
[TBL] [Abstract][Full Text] [Related]
14. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
[TBL] [Abstract][Full Text] [Related]
15. Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer.
Berkel C; Cacan E
Biochem Biophys Res Commun; 2021 Sep; 570():74-81. PubMed ID: 34273621
[TBL] [Abstract][Full Text] [Related]
16. The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity.
Mirzoeva OK; Kawaguchi T; Pieper RO
Mol Cancer Ther; 2006 Nov; 5(11):2757-66. PubMed ID: 17121922
[TBL] [Abstract][Full Text] [Related]
17. The ends in sight: Mre11-Rad50-Nbs1 complex structures come into focus.
Wojtaszek JL; Williams RS
Mol Cell; 2023 Jan; 83(2):160-162. PubMed ID: 36669476
[TBL] [Abstract][Full Text] [Related]
18. C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex.
Bai Y; Wang W; Li S; Zhan J; Li H; Zhao M; Zhou XA; Li S; Li X; Huo Y; Shen Q; Zhou M; Zhang H; Luo J; Sung P; Zhu WG; Xu X; Wang J
Mol Cell; 2019 Sep; 75(6):1299-1314.e6. PubMed ID: 31353207
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinase USP2 stabilizes the MRE11-RAD50-NBS1 complex at DNA double-strand break sites by counteracting the ubiquitination of NBS1.
Kim H; Kim D; Choi H; Shin G; Lee JK
J Biol Chem; 2023 Jan; 299(1):102752. PubMed ID: 36436562
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Mre11-Rad50-Nbs1 complex in cisplatin nephrotoxicity.
Kim YJ; Kim TW; Park SR; Kim HT; Ryu SY; Jung JY
Environ Toxicol Pharmacol; 2015 Jul; 40(1):12-7. PubMed ID: 26056972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
